HER2 activates RAS by interacting with Grb2 and SOS [123]; however, the predominant downstream signaling pathway may vary based on tumor type, with prevalent activation of PI3K over ERK pathway in breast cancer [124,125]. This evidence concerns the gene MAPK1 and breast cancer.